Cancer Vaccine Safe, Induces T-Cell Responses for KRAS-Mutated Tumors
FRIDAY, Jan. 12, 2024 (HealthDay News) -- For patients with immunotherapy recalcitrant KRAS-mutated tumors, the cancer vaccine ELI-002 2P is safe and induces T-cell responses, according to ...